HomeICCC • NASDAQ
add
ImmuCell Corp
Previous close
$3.76
Day range
$3.55 - $3.79
Year range
$3.35 - $5.54
Market cap
32.44M USD
Avg Volume
16.45K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 6.01M | 11.40% |
Operating expense | 2.16M | -11.93% |
Net income | -701.69K | 25.35% |
Net profit margin | -11.67 | 33.01% |
Earnings per share | — | — |
EBITDA | 100.23K | 120.72% |
Effective tax rate | -0.19% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.81M | 91.44% |
Total assets | 44.45M | -0.22% |
Total liabilities | 18.04M | -2.67% |
Total equity | 26.41M | — |
Shares outstanding | 8.91M | — |
Price to book | 1.26 | — |
Return on assets | -3.33% | — |
Return on capital | -3.54% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -701.69K | 25.35% |
Cash from operations | -639.33K | -25.91% |
Cash from investing | -88.41K | 83.42% |
Cash from financing | 3.21M | 103.79% |
Net change in cash | 2.48M | 364.23% |
Free cash flow | -441.59K | 60.87% |
About
Founded
1982
Headquarters
Website
Employees
77
